-
Mashup Score: 28Register | TCT Middle East 2025 - 18 day(s) ago
Take advantage of early-bird registration through 28 January 2025. All figures are in SAR. Rate changes take effect at 12:00 AM SAST (UTC +3). *Fellows: See Terms and Conditions below. **Available to Saudi government employees with a valid government ID. Get the latest news and information from CRF. © 2024, Cardiovascular Research Foundation ®. All rights reserved.
Categories: General Medicine News, CardiologistsTweet
-
Mashup Score: 28Register | TCT Middle East 2025 - 18 day(s) ago
Take advantage of early-bird registration through 28 January 2025. All figures are in SAR. Rate changes take effect at 12:00 AM SAST (UTC +3). *Fellows: See Terms and Conditions below. **Available to Saudi government employees with a valid government ID. Get the latest news and information from CRF. © 2024, Cardiovascular Research Foundation ®. All rights reserved.
Categories: General Medicine News, CardiologistsTweet-
🌍 Step into the future of cardiovascular care at #TCTMiddleEast2025! Join leading experts and innovators in shaping the region's healthcare landscape. 🗓️ Early-bird registration ends 28 January 2025. Secure your spot now! https://t.co/3iM590u3wu #CardioX #CardioTwitter… https://t.co/PvkbylWU0B https://t.co/a1pJcmkwZs
-
-
Mashup Score: 21Artificial Intelligence-Based Fully Automated Quantitative Coronary Angiography Versus Optical Coherence Tomography Guided PCI (FLASH Trial): - 30 day(s) ago
AbstractBackgroundRecently developed artificial intelligence-based fully automated quantitative coronary angiography (AI-QCA) provides real-time, objective, and reproducible quantitative analysis o…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
FLASH Trial results are here! ⚡ AI-based fully automated quantitative coronary angiography achieves outcomes comparable to OCT-guided PCI. Findings unveiled at #TCT2024 and published in JACC: Cardiovascular Interventions. @JACCJournals https://t.co/5zuMI0LAQz #CardioX… https://t.co/kuSAMl8qGU https://t.co/2P2Ok001sm
-
-
Mashup Score: 23Register | TCT Middle East 2025 - 1 month(s) ago
Take advantage of early-bird registration through 28 January 2025. All figures are in SAR. Rate changes take effect at 12:00 AM SAST (UTC +3). *Fellows: See Terms and Conditions below. **Available to Saudi government employees with a valid government ID. Get the latest news and information from CRF. © 2024, Cardiovascular Research Foundation ®. All rights reserved.
Categories: General Medicine News, CardiologistsTweet-
🌍 Step into the future of cardiovascular care at #TCTMiddleEast2025! Join leading experts and innovators in shaping the region's healthcare landscape. 🗓️ Early-bird registration ends 28 January 2025. Secure your spot now! https://t.co/3iM590u3wu #CardioX #CardioTwitter… https://t.co/PvkbylWU0B https://t.co/a1pJcmkwZs
-
-
Mashup Score: 27
Background: There is a lack of randomized controlled trial (RCT) data comparing outcomes of different catheter-based interventions for intermediate-risk pulmonary embolism (PE). Methods: PEERLESS is a prospective, multicenter, RCT that enrolled 550 intermediate-risk PE patients with right ventricular dilatation and additional clinical risk factors randomized 1:1 to treatment with large-bore mechanical thrombectomy (LBMT) or catheter-directed thrombolysis (CDT). The primary endpoint was a hierarchal win ratio (WR) composite of the following: 1) all-cause mortality, 2) intracranial hemorrhage, 3) major bleeding, 4) clinical deterioration and/or escalation to bailout, and 5) postprocedural intensive care unit (ICU) admission and length of stay, assessed at the sooner of hospital discharge or 7 days post-procedure. Assessments at the 24-hour visit included respiratory rate, mMRC dyspnea score, NYHA classification, right ventricle (RV)/left ventricle (LV) ratio reduction, and RV function. E
Source: www.ahajournals.orgCategories: General Medicine News, Cardiology News and JournTweet-
#PEERLESS reveals benefits of large-bore mechanical thrombectomy over catheter-directed thrombolysis for intermediate-risk PE. 🚀 Results presented at #TCT2024 and published in @CircAHA. https://t.co/1nuCoj9ahv #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd… https://t.co/eC64AqWO9v https://t.co/wkW3rYt7VP
-
-
Mashup Score: 29Transcatheter Aortic-Valve Replacement for Asymptomatic Severe Aortic Stenosis | NEJM - 2 month(s) ago
For patients with asymptomatic severe aortic stenosis and preserved left ventricular ejection fraction, current guidelines recommend routine clinical surveillance every 6 to 12 months. Data from ra…
Source: www.nejm.orgCategories: General Medicine News, CardiologistsTweet-
#TAVR may offer benefits for patients with asymptomatic severe aortic stenosis. 🫀💡 Findings were unveiled today at #TCT2024 and published in @NEJM. https://t.co/On2iYIXC0I #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795 @georgedangas @jgranadacrf… https://t.co/eQzIPFjYOH https://t.co/GANElXUeDp
-
-
Mashup Score: 1CRF Connect - 2 month(s) ago
1700 Broadway, 9th Floor New York, NY 10019 (646) 434-4500 © 2023, Cardiovascular Research Foundation. All rights reserved. This website uses cookies to ensure you get the best experience on our website. Read
Source: www.crfconnect.comCategories: General Medicine News, Cardiology News and JournTweet
-
Mashup Score: 25
Request permissions for this article. Department of General and Interventional Cardiology/Angiology, Heart and Diabetes Center NRW, University Hospital of the Ruhr-University Bochum, Medical Faculty OWL, Bad Oeynhausen, Germany Department of Cardiology, Cardiology I, University Medical Center of the Johannes Gutenberg-University Mainz, and the German Center for Cardiovascular Research (DZHK) partner site Rhine Main, Mainz, Germany University of Cologne, Faculty of Medicine and University Hospital
Source: www.ahajournals.orgCategories: General Medicine News, CardiologistsTweet-
New post-hoc analysis from the MATTERHORN trial compares transcatheter repair vs. surgery in atrial mitral regurgitation. 📈 Findings presented at #TCT2024 and published in @CircAHA. https://t.co/Ks042ljBJW #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795… https://t.co/7QHzr7klDn https://t.co/fDFtTrTrrs
-
-
Mashup Score: 15Randomized Comparison of Novel Low-Dose Sirolimus-Eluting Biodegradable Polymer Stent vs Second-Generation DES: TARGET-IV NA Trial - 2 month(s) ago
AbstractBackgroundDrug-eluting stents (DESs) with controlled antiproliferative drug release reduce restenosis risk, but durable polymers can delay healing and inhibit reendothelialization. The Fire…
Source: www.jacc.orgCategories: General Medicine News, Cardiology News and JournTweet-
TARGET-IV Trial compares a novel low-dose sirolimus-eluting biodegradable polymer stent with second-generation DES. 📊 Presented today at #TCT2024 and now featured in JACC. https://t.co/CkNH60oMBi #CardioX #CardioTwitter #CardioEd #CardioResearch @BurkhoffMd @djc795… https://t.co/49O6wqMc7g https://t.co/KqszcwObvd
-
-
Mashup Score: 22CRF Connect - 2 month(s) ago
1700 Broadway, 9th Floor New York, NY 10019 (646) 434-4500 © 2023, Cardiovascular Research Foundation. All rights reserved. This website uses cookies to ensure you get the best experience on our website. Read
Source: www.crfconnect.comCategories: General Medicine News, Cardiology News and JournTweet
🌍 Step into the future of cardiovascular care at #TCTMiddleEast2025! Join leading experts and innovators in shaping the region's healthcare landscape. 🗓️ Early-bird registration ends 28 January 2025. Secure your spot now! https://t.co/3iM590u3wu #CardioX #CardioTwitter… https://t.co/PvkbylWU0B https://t.co/a1pJcmkwZs